|
|
FDA Recall
Early Alert: Infusion Pump Issue from Baxter Healthcare CorporationThis communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. The FDA has become aware of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available.
|
|
KCER Release Date: March 5, 2025 To: KCER Distribution list- including ESRD Network EDs and QIDs Affected Product
The FDA is aware that Baxter Healthcare Corporation has issued a letter to affected customers recommending certain Spectrum infusion pumps be removed from where they are used or sold:
What to Do
Reason for Early Alert Baxter Healthcare Corporation recalled the Spectrum infusion pumps due to the potential for missing motor mounting screws, which may have occurred during the servicing process. Baxter is requesting the return of the affected pumps for inspection and reservicing as applicable. Missing motor mounting screws may lead to insufficient or excessive therapy, interruption in therapy, or delay in therapy, which can result in serious adverse health consequences. Baxter has reported one serious injury related to this issue.
Device Use These Baxter Spectrum infusion pumps are intended to be used for the controlled administration of fluids—including medicine, blood, and blood products—to patients.
Contact Information Customers in the U.S. with questions should contact your Baxter sales representative or Baxter Global Technical Services at 800-843-7867 Monday through Friday, between 7:00 am and 7:00 pm Eastern Time.
Unique Device Identifier (UDI) The unique device identifier (UDI) helps identify individual medical devices sold in the United States from distribution to use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified more quickly, and as a result, problems potentially resolved more quickly.
How do I report a problem? Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.
|